Covered Stocks

Jason Cassorla

Work

Analyst Jason Cassorla works at CITI and is focused on the Healthcare sector with 131 price targets and ratings documented since 2017 spanning on 9 stocks. Analyst's average stock valuation to be materialised ratio is 41.25% with an average time for price targets to be met of 99 days.

Most recent stock forecast was given on HCA, HCA Healthcare, Inc at 30-Jan-2023.

Jason Cassorla best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP - CLASS A).
The best stock recommendation documented was for CLOV (CLOVER HEALTH INVESTMENTS CORP - CLASS A) at 8/9/2022. The price target of $3 was fulfilled within 1 day with a profit of $0.21 (7.53%) receiving and performance score of 75.27.

Average potential price target upside

AGTI BHG CANO CYH HCA SGRY THC CLOV UHS

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

20

$1.05 (5.54%)

22

2 months 20 days ago

1/6 (16.67%)

$4.39 (22.79%)

48

Buy

21

$2.05 (10.82%)

25

2 months 21 days ago

1/4 (25%)

$6.04 (34.74%)

7

Buy

20

$1.05 (5.54%)

24

2 months 21 days ago

0/3 (0%)

$8.03 (45.24%)

Buy

23

$4.05 (21.37%)

25

2 months 24 days ago

2/5 (40%)

$5.94 (35.51%)

15

Buy

20

$5.13 (34.50%)

23

3 months 24 days ago

0/4 (0%)

$5.27 (30.06%)

Show more analysts
AGTI BHG CANO CYH HCA SGRY THC CLOV UHS